Literature DB >> 11144332

Evaluation of immune survival factors in pediatric HIV-1 infection.

W T Shearer1, K A Easley, J Goldfarb, H B Jenson, H M Rosenblatt, A Kovacs, K McIntosh.   

Abstract

Peripheral blood CD4+ and CD8+ T cells, CD19+/20+ B cells, and serum immunoglobulins (Igs) have been implicated as survival factors for pediatric HIV-1 infection. To determine which of these immune factors might be important in predicting survival, we studied HIV-1 vertically infected (HIV-1+) children over a 5-year period. Peripheral blood lymphocytes and Igs were measured in 298 HIV-1+ children, who were classified as survivors or nonsurvivors, and in 463 HIV-1 vertically exposed and noninfected (HIV-1-) children. Measurements of other possible survival factors were included in this study: albumin, hemoglobin, lactic dehydrogenase (LDH), and HIV-1 RNA levels. Survivors had significantly higher CD4+ T-cell, CD8+ T-cell, and CD19+/CD20+ B-cell counts and serum IgG levels, but lower serum IgA and IgM levels than nonsurvivors. Serum albumin and blood hemoglobin levels were higher, but serum LDH and HIV-1 RNA levels were lower in the survivors compared to nonsurvivors. In univariable analysis, factors affecting survival were baseline CD4+ T-cell and CD8+ T-cell counts, IgG, albumin, hemoglobin, LDH, and HIV-1 RNA (all p < 0.001). In multivariable analysis, high baseline CD4+ T-cell count, IgG and albumin levels, and low baseline HIV-1 RNA load remained important factors for survival. Serum IgG level has been identified as an immune factor that independently predicts survival, in addition to the already established CD4+ T-cell count. The HIV-1 RNA and serum albumin levels also predicted survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11144332      PMCID: PMC4412260          DOI: 10.1111/j.1749-6632.2000.tb05499.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  28 in total

1.  Low number of functionally active B lymphocytes in the peripheral blood of HIV-1-seropositive individuals with low p24-specific serum antibody titers.

Authors:  V J Teeuwsen; J M Lange; R Keet; J K Schattenkerk; C Debouck; R van den Akker; J Goudsmit; A D Osterhaus
Journal:  AIDS       Date:  1991-08       Impact factor: 4.177

2.  Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group.

Authors:  W T Shearer; S E Lipshultz; K A Easley; K McIntosh; J Pitt; T C Quinn; M Kattan; J Goldfarb; E Cooper; Y Bryson; A Kovacs; J T Bricker; H Peavy; R B Mellins; N Heart; L B Institute
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

3.  Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group.

Authors:  A Kovacs; M Schluchter; K Easley; G Demmler; W Shearer; P La Russa; J Pitt; E Cooper; J Goldfarb; D Hodes; M Kattan; K McIntosh
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

4.  Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

Authors:  L M Mofenson; D R Harris; K Rich; W A Meyer; J S Read; J Moye; R P Nugent; J Korelitz; J Bethel; S Pahwa
Journal:  AIDS       Date:  1999-01-14       Impact factor: 4.177

5.  Characteristics of children surviving to 5 years of age or older with vertically acquired HIV infection.

Authors:  M W Kline; M E Paul; B Bohannon; C A Kozinetz; W T Shearer
Journal:  Pediatr AIDS HIV Infect       Date:  1995-12

6.  Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; G Sopko; S D Colan
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

7.  CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survival.

Authors:  H Pollack; M X Zhan; J T Safrit; S H Chen; G Rochford; P Z Tao; R Koup; K Krasinski; W Borkowsky
Journal:  AIDS       Date:  1997-01       Impact factor: 4.177

8.  Predictive value of CD19 measurements for bacterial infections in children infected with human immunodeficiency virus.

Authors:  R A Betensky; T Calvelli; S Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

9.  Longitudinal study of 18 children with perinatal LAV/HTLV III infection: attempt at prognostic evaluation.

Authors:  S Blanche; F Le Deist; A Fischer; F Veber; M Debre; S Chamaret; L Montagnier; C Griscelli
Journal:  J Pediatr       Date:  1986-12       Impact factor: 4.406

10.  Bacterial infection in the acquired immunodeficiency syndrome of children.

Authors:  L J Bernstein; B Z Krieger; B Novick; M J Sicklick; A Rubinstein
Journal:  Pediatr Infect Dis       Date:  1985 Sep-Oct
View more
  8 in total

Review 1.  Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.

Authors:  Alberto Cagigi; Nicola Cotugno; Carlo Giaquinto; Luciana Nicolosi; Stefania Bernardi; Paolo Rossi; Iyadh Douagi; Paolo Palma
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

2.  Persistently high IgA serum levels are a marker of immunological or virological failure of combined antiretroviral therapy in children with perinatal HIV-1 infection.

Authors:  Elena Chiappini; Luisa Galli; Pier-Angelo Tovo; Clara Gabiano; Maurizio de Martino
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

3.  CD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study.

Authors:  Savita Pahwa; Jennifer S Read; Wanrong Yin; Yvonne Matthews; William Shearer; Clemente Diaz; Kenneth Rich; Hermann Mendez; Bruce Thompson
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

4.  Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children.

Authors:  Elizabeth M Obimbo; Dorothy A Mbori-Ngacha; James O Ochieng; Barbra A Richardson; Phelgona A Otieno; Rose Bosire; Carey Farquhar; Julie Overbaugh; Grace C John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2004-06       Impact factor: 2.129

5.  Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy.

Authors:  Hal B Jenson; Charles J Gauntt; Kirk A Easley; Jane Pitt; Steven E Lipshultz; Kenneth McIntosh; William T Shearer
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

6.  Patterns and predictors of CD4 T-cell counts among children born to HIV-infected women in Tanzania.

Authors:  Roland Kupka; Gernard I Msamanga; Said Aboud; Karim P Manji; Christopher Duggan; Wafaie W Fawzi
Journal:  J Trop Pediatr       Date:  2009-01-21       Impact factor: 1.165

Review 7.  Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment.

Authors:  Nicola Cotugno; Iyadh Douagi; Paolo Rossi; Paolo Palma
Journal:  Clin Dev Immunol       Date:  2012-04-08

8.  Exposure to low-dose arsenic in early life alters innate immune function in children.

Authors:  Faruque Parvez; Evana Akhtar; Lamia Khan; Md Ahsanul Haq; Tariqul Islam; Dilruba Ahmed; Hem Mahbubul Eunus; Akm Rabiul Hasan; Habibul Ahsan; Joseph H Graziano; Rubhana Raqib
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.439

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.